Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1155-1165

  Luca Harari, Bogdan ^a   Darenberg, Jessica ^b   Neal, Shona ^c   Siljander, Tuula ^d   Strakova, Lenka ^e   Tanna, Asha ^c   Creti, Roberta ^f   Ekelund, Kim ^g   Koliou, Maria ^h   Tassios, Panayotis T ⁱ   Van Der Linden, Mark ^j   Straut, Monica ^k   Vuopio Varkila, Jaana ^d   Bouvet, Anne ^l   Efstratiou, Androulla ^c   Schalén, Claes ^a   Henriques Normark, Birgitta ^b   Jasir, Aftab ^a  

^a LUND UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g STATENS SERUM INSTITUT   (Denmark)

^h Archbishop Makarios Hospital   (Cyprus)

ⁱ UNIVERSITY OF ATHENS   (Greece)

^j UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^k CANTACUZINO INSTITUTE   (Romania)

^l HÔTEL DIEU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS VACCINE; BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN; SUPERANTIGEN;

ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CZECH REPUBLIC; DENMARK; DISEASE SEVERITY; EUROPE; FINLAND; FRANCE; HUMAN; MAJOR CLINICAL STUDY; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; ROMANIA; SEASONAL VARIATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME; ADOLESCENT; ADULT; AGE; AGED; BACTERIUM IDENTIFICATION; CHILD; CLASSIFICATION; FEMALE; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEPTIC SHOCK;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; EUROPE; FASCIITIS, NECROTIZING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; YOUNG ADULT;

EID: 65249093620     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02155-08     Document Type: Article

References (51)

1. Aguiar, S. I., I. Serrano, F. R. Pinto, J. Melo-Cristino, and M. Ramirez. 2008. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin. Microbiol. Infect. 14:835-843.
2. Areschoug, T., F. Carlsson, M. Stalhammar-Carlemalm, and G. Lindahl. 2004. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development. Vaccine 22 (Suppl. 1) :S9-S14.
3. 2-terminal region of type 6 streptococcal M protein. J. Immunol. 136:2287-2292.
4. Beachey, E. H., J. M. Seyer, J. B. Dale, W. A. Simpson, and A. H. Kang. 1981. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature 292:457-459.
5. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
6. Beres, S. B., G. L. Sylva, D. E. Sturdevant, C. N. Granville, M. Liu, S. M. Ricklefs, A. R. Whitney, L. D. Parkins, N. P. Hoe, G. J. Adams, D. E. Low, F. R. DeLeo, A. McGeer, and J. M. Musser. 2004. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. USA 101:11833-11838.
7. Bessen, D. E., C. M. Sotir, T. L. Readdy, and S. K. Hollingshead. 1996. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173:896-900.
8. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3:191-200.
9. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685694.
10. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534.
11. Cleary, P., D. Johnson, and L. Wannamaker. 1979. Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift. J. Infect. Dis. 140:747-757.
12. Colman, G., A. Tanna, A. Efstratiou, and E. T. Gaworzewska. 1993. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J. Med. Microbiol. 39:165-178.
13. Creti, R., M. Imperi, L. Baldassarri, M. Pataracchia, S. Recchia, G. Alfarone, and G. Orefici. 2007. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J. Clin. Microbiol. 45:2249-2256.
14. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
15. Dale, J. B. 2008. Current status of group A streptococcal vaccine development. Adv. Exp. Med. Biol. 609:53-63.
16. Dale, J. B., and E. H. Beachey. 1986. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J. Exp. Med. 163: 1191-1202.
17. Dale, J. B., T. Penfound, E. Y. Chiang, V. Long, S. T. Shulman, and B. Beall. 2005. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin. Diagn. Lab. Immunol. 12: 833-836.
18. Darenberg, J., B. Luca-Harari, A. Jasir, A. Sandgren, H. Pettersson, C. Schalen, M. Norgren, V. Romanus, A. Norrby-Teglund, and B. H. Normark. 2007. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45:450-458.
19. Davies, H. D., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, D. E. Low, et al. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335:547-554.
20. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45 (Suppl.) :3-12.
21. Facklam, R. 2002. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15:613-630.
22. Facklam, R., B. Beall, A. Efstratiou, V. Fischetti, D. Johnson, E. Kaplan, P. Kriz, M. Lovgren, D. Martin, B. Schwartz, A. Totolian, D. Bessen, S. Hollingshead, F. Rubin, J. Scott, and G. Tyrrell. 1999. emm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis. 5:247253.
23. Fischetti, V. A., K. F. Jones, S. K. Hollingshead, and J. R. Scott. 1988. Structure, function, and genetics of streptococcal M protein. Rev. Infect. Dis. 10 (Suppl. 2) :S356-S359.
24. Green, N. M., S. Zhang, S. F. Porcella, M. J. Nagiec, K. D. Barbian, S. B. Beres, R. B. LeFebvre, and J. M. Musser. 2005. Genome sequence of a serotype M28 strain of group A streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192:760770.
25. Johnson, D. R., and E. L. Kaplan. 1993. A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci. J. Med. Microbiol. 38:311-315.
26. Johnson, D. R., E. L. Kaplan, A. VanGheem, R. R. Facklam, and B. Beall. 2006. Characterization of group A streptococci (Streptococcus pyogenes) : correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55:157-164.
27. Jones, K. F., B. N. Manjula, K. H. Johnston, S. K. Hollingshead, J. R. Scott, and V. A. Fischetti. 1985. Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J. Exp. Med. 161:623-628.
28. Kotb, M., A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M. T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, B. Schwartz, and D. E. Low. 2002.
29. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:13981404.
30. Lamagni, T. L., J. Darenberg, B. Luca-Harari, T. Siljander, A. Efstratiou, B. Henriques-Normark, J. Vuopio-Varkila, A. Bouvet, R. Creti, K. Ekelund, M. Koliou, R. R. Reinert, A. Stathi, L. Strakova, V. Ungureanu, C. Schalen, and A. Jasir. 2008. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 46:2359-2367.
31. Luca-Harari, B., K. Ekelund, M. van der Linden, M. Staum-Kaltoft, A. M. Hammerum, and A. Jasir. 2008. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46:79-86.
32. Mencarelli, M., R. Corbisiero, M. G. Padula, I. Galgani, L. Stolzuoli, and C. Cellesi. 2005. Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002. Epidemiol. Infect. 133:1107-1111.
33. Mihaila-Amrouche, L., A. Bouvet, and J. Loubinoux. 2004. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J. Clin. Microbiol. 42:3844-3846.
34. Neal, S., B. Beall, K. Ekelund, B. Henriques-Normark, A. Jasir, D. Johnson
35. E. Kaplan, M. Lovgren, R. R. Reinert, and A. Efstratiou. 2007. International quality assurance study for characterization of Streptococcus pyogenes. J. Clin. Microbiol. 45:1175-1179.
36. Norrby-Teglund, A., G. T. Nepom, and M. Kotb. 2002. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur. J. Immunol. 32:2570-2577.
37. O'Loughlin, R. E., A. Roberson, P. R. Cieslak, R. Lynfield, K. Gershman, A. Craig, B. A. Albanese, M. M. Farley, N. L. Barrett, N. L. Spina, B. Beall, L. H. Harrison, A. Reingold, and C. Van Beneden. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862.
38. Raymond, J., L. Schlegel, F. Garnier, and A. Bouvet. 2005. Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis. Infect. Control Hosp. Epidemiol. 26:455-461.
39. Spindler, C., J. Hedlund, A. Jasir, B. H. Normark, and A. Ortqvist. 2008. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine 26:55415546.
40. Stalhammar-Carlemalm, M., T. Areschoug, C. Larsson, and G. Lindahl. 2000. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins. J. Infect. Dis. 182:142-149.
41. Stalhammar-Carlemalm, M., T. Areschoug, C. Larsson, and G. Lindahl. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219.
42. Stevens, D. L. 1999. The flesh-eating bacterium: what's next? J. Infect. Dis. 179 (Suppl. 2) :S366-S374.
43. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis. 14:2-11.
44. Stevens, D. L. 1995. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. Dis. 1:69-78.
45. Strakova, L., J. Motlova, P. Urbaskova, and P. Krizova. 2004. Surveillance of serious diseases caused by group A streptococci in the Czech Republic in 2003-the Strep-EURO project. Epidemiol. Mikrobiol. Imunol. 53:106-111. (In Czech.)
46. Svensson, N., S. Oberg, B. Henriques, S. Holm, G. Kallenius, V. Romanus, and J. Giesecke. 2000. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand. J. Infect. Dis. 32:609-614.
47. Tyrrell, G. J., M. Lovgren, B. Kress, and K. Grimsrud. 2005. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J. Clin. Microbiol. 43:1678-1683.
48. Vlaminckx, B., W. van Pelt, L. Schouls, A. van Silfhout, C. Elzenaar, E. Mascini, J. Verhoef, and J. Schellekens. 2004. Epidemiological features of invasive and noninvasive group A streptococcal disease in The Netherlands, 1992-1996. Eur. J. Clin. Microbiol. Infect. Dis. 23:434-444.
49. Wahl, R. U., R. Lutticken, S. Stanzel, M. van der Linden, and R. R. Reinert. 2007. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin. Microbiol. Infect. 13:1173-1178.
50. The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391.
51. Zhang, S., N. M. Green, I. Sitkiewicz, R. B. Lefebvre, and J. M. Musser. 2006. Identification and characterization of an antigen I/II family protein produced by group A streptococcus. Infect. Immun. 74:4200-4213.